SURG

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 10.58 M11.52 M18.68 M16.19 M15.98 M 62.37 M Gross profit -2.94 M-2.65 M-2.6 M-2.4 M-7.7 M -15.34 M Operating expenses 4.64 M4.16 M4.35 M6.92 M3.5 M 18.94 M Selling/general/admin expenses 4.64 M4.16 M4.35 M6.92 M3.5 M 18.94 M Research & development ————— — Operating income -7.58 M-6.81 M-6.95 M-12.8 M-11.2 M -37.76 M Non-Operating Income, Total -55.39 K-272.3 K-539.16 K-1.07 M-851.67 K -2.73 M Interest expense, net of interest capitalized 238.87 K212.42 K424.67 K1.25 M881.91 K 2.77 M Non-Operating Income, excl. Interest Expenses -55.39 K-272.3 K-539.16 K-1.07 M-851.67 K -2.73 M Unusual income/expense 7 140-35535500 0 Pretax income -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M -40.49 M Equity in earnings ————— — Taxes 00000 0 Non-controlling/minority interest -209-209-227-193-151 -780 After tax other income/expense ————— — Net income before discontinued operations -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M -40.48 M Discontinued operations 0———— — Net income -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M -40.48 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -7.64 M-7.08 M-7.49 M-13.86 M-12.05 M -40.48 M Basic earnings per share (Basic EPS) -0.38-0.36-0.38-0.68-0.51 -1.93 Diluted earnings per share (Diluted EPS) -0.38-0.36-0.38-0.68-0.51 -1.93 Average basic shares outstanding 20.07 M19.89 M19.84 M20.09 M23.7 M — Diluted shares outstanding 20.07 M19.89 M19.84 M20.09 M23.7 M — EBITDA -7.49 M-6.74 M-6.92 M-12.77 M-11.17 M -37.61 M EBIT -7.58 M-6.81 M-6.95 M-12.8 M-11.2 M -37.76 M Cost of revenue 13.52 M14.17 M21.28 M18.58 M23.68 M 77.71 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 86.12 K66.36 K26.84 K26.84 K26.84 K 146.88 K